Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Single Arm Observational Cohort Study of Ultrasound Guided Intra Ovarian Injection of Muse Cells (Multilineage Differentiating Stress-Enduring Cells) for Reversal of Perimenopausal Ovarian Decline in Women Aged 28-70 Years

NCT07511660 is registered in ClinicalTrials.gov with Healing Hope International as lead sponsor.

NCT NCT07511660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07511660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Single Arm Observational Cohort Study of Ultrasound Guided Intra Ovarian Injection of Muse Cells (Multilineage Differentiating Stress-Enduring Cells) for Reversal of Perimenopausal Ovarian Decline in Women Aged 28-70 Years
Lead sponsor
Healing Hope International
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 1, 2026
Completion date
July 30, 2030
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cell therapy, diminished ovarian reserve, diminished ovarian reserve (dor), diminished ovarian reserve due to advanced maternal age, hormonal imbalance, hormone disturbance, menopause, menopause hot flashes, menopause ovarian failure, ovarian dysfunction, perimenopause, perimenopause-related depression, premature ovarian failure, premature ovarian failure (pof), premature ovarian insufficiency, quality of life, quality of life and menopause, vasomotor symptoms, vasomotor symptoms (vms), vasomotor symptoms as a sex hormone-dependent disorder in women and men, vasomotor symptoms associated with menopause, womens health